Corient Private Wealth LLC Boosts Holdings in Corteva, Inc. (NYSE:CTVA)

Corient Private Wealth LLC lifted its stake in Corteva, Inc. (NYSE:CTVA) by 4.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 224,732 shares of the company’s stock after buying an additional 10,259 shares during the period. Corient Private Wealth LLC’s holdings in Corteva were worth $12,801,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the stock. Diversified Enterprises LLC grew its position in shares of Corteva by 8.6% in the 4th quarter. Diversified Enterprises LLC now owns 4,950 shares of the company’s stock valued at $282,000 after buying an additional 393 shares during the last quarter. Natixis Advisors LLC grew its position in shares of Corteva by 4.3% in the 4th quarter. Natixis Advisors LLC now owns 1,697,707 shares of the company’s stock valued at $96,700,000 after buying an additional 70,400 shares during the last quarter. Intact Investment Management Inc. grew its position in shares of Corteva by 76.7% in the 4th quarter. Intact Investment Management Inc. now owns 12,300 shares of the company’s stock valued at $701,000 after buying an additional 5,340 shares during the last quarter. Commonwealth Equity Services LLC grew its position in shares of Corteva by 1.7% in the 4th quarter. Commonwealth Equity Services LLC now owns 140,970 shares of the company’s stock valued at $8,030,000 after buying an additional 2,309 shares during the last quarter. Finally, HBK Sorce Advisory LLC grew its position in shares of Corteva by 11.8% in the 4th quarter. HBK Sorce Advisory LLC now owns 7,710 shares of the company’s stock valued at $439,000 after buying an additional 814 shares during the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Corteva

In other Corteva news, insider Brian Titus sold 26,560 shares of the company’s stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the sale, the insider now owns 11,347 shares of the company’s stock, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.20% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Royal Bank of Canada lifted their price objective on shares of Corteva from $72.00 to $73.00 and gave the company an “outperform” rating in a research note on Friday, February 7th. The Goldman Sachs Group assumed coverage on shares of Corteva in a research note on Thursday, March 13th. They issued a “buy” rating and a $71.00 price objective on the stock. Oppenheimer lifted their price objective on shares of Corteva from $70.00 to $72.00 and gave the company an “outperform” rating in a research note on Friday, February 7th. Wells Fargo & Company lifted their price objective on shares of Corteva from $67.00 to $73.00 and gave the company an “overweight” rating in a research note on Tuesday, January 28th. Finally, Bank of America lifted their price objective on shares of Corteva from $69.00 to $73.00 and gave the company a “buy” rating in a research note on Tuesday, February 11th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $68.00.

Corteva Stock Up 1.5 %

CTVA stock opened at $62.50 on Thursday. The company has a market cap of $42.85 billion, a P/E ratio of 48.45, a P/E/G ratio of 1.68 and a beta of 0.79. Corteva, Inc. has a 52 week low of $50.01 and a 52 week high of $66.24. The company’s 50-day moving average price is $62.25 and its 200 day moving average price is $59.79. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Monday, March 3rd were issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date of this dividend was Monday, March 3rd. Corteva’s dividend payout ratio is currently 52.71%.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.